TERADYNE, INC false 0000097210 0000097210 2020-04-21 2020-04-21










Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 21, 2020



(Exact Name of Registrant as Specified in Charter)







(State or Other Jurisdiction

of Incorporation)



File Number)


(IRS Employer

Identification No.)

600 Riverpark Drive, North Reading, MA



(Address of Principal Executive Offices)


(Zip Code)

Registrant’s telephone number, including area code: (978) 370-2700

(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class





Name of each exchange

on which registered

Common Stock, par value $0.125 per share




Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.02 Results of Operations and Financial Condition.

On April 21, 2020, Teradyne, Inc. (“Teradyne”) issued a press release regarding its financial results for the first quarter ended March 29, 2020. Teradyne’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.







Press Release dated April 21, 2020.




Cover Page Interactive Data File (embedded within the Inline XBRL document)


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.





Dated: April 22, 2020










Sanjay Mehta





Vice President, Chief Financial Officer and Treasurer


Exhibit 99.1

Teradyne Reports First Quarter 2020 Results



Revenue of $704 million in Q1’20, growth of 43% from Q1’19



Test revenue grew 50% from Q1’19



Industrial Automation revenue declined 9% from Q1’19 on global manufacturing weakness



Share repurchase program suspended as of April 1, 2020


     Q1’20      Q1’19      Q4’19  

Revenue (mil)

   $ 704      $ 494      $ 655  


   $ 0.97      $ 0.62      $ 0.69  


   $ 1.00      $ 0.54      $ 0.88  


NORTH READING, Mass. – April 21, 2020 – Teradyne, Inc. (NASDAQ: TER) reported revenue of $704 million for the first quarter of 2020 of which $484 million was in Semiconductor Test, $116 million in System Test, $60 million in Industrial Automation (IA) and $43 million in Wireless Test. GAAP net income for the first quarter was $176.2 million or $0.97 per diluted share. On a non-GAAP basis, Teradyne’s net income in the first quarter was $172.5 million, or $1.00 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, non-cash convertible debt interest, discrete tax adjustments and included the related tax impact on non-GAAP adjustments.

“First quarter sales and earnings were in line with our January guidance through the extraordinary efforts of our operations team, their supply line partners, and our customer support teams,” said CEO and President Mark Jagiela. “Production ramps of recent design wins in our System on a Chip and Memory test units continued as planned and the climate in our test businesses remains cautiously positive. However, our Industrial Automation results were below plan as we faced considerable headwinds from the COVID-19 related impacts on global manufacturing activity.

“While test demand remains strong entering the second quarter and our balance sheet has over $900 million in available cash, the impacts of the global pandemic on short term Test and Industrial Automation demand remain uncertain. As a result, we are prudently managing our cash flow and have suspended our share repurchase program until there is more clarity on the economic front. Our second quarter guidance ranges are broader than usual to reflect that demand and supply uncertainty.”

Guidance for the second quarter of 2020 is revenue of $690 million to $800 million, with GAAP net income of $0.76 to $1.05 per diluted share and non-GAAP net income of $0.86 to $1.16 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest and includes the related tax impact on non-GAAP adjustments.

Page 2



A conference call to discuss the first quarter results, along with management’s business outlook, will follow at 8:30 a.m. ET, Wednesday, April 22. Interested investors should access the webcast at investors.teradyne.com/events-presentations at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on Teradyne’s Investor Relations site at investors.teradyne.com.

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, non-cash convertible debt interest, pension actuarial gains and losses, discrete income tax adjustments, fair value inventory step-up, and restructuring and other, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP gross margin excludes fair value inventory step-up. GAAP requires that this item be included in determining gross margin. Non-GAAP gross margin dollar amount and percentage are non-GAAP performance measures that management believes provide useful supplemental information for management and the investor. Management uses non-GAAP gross margin as a performance measure for Teradyne’s current core business and future outlook and for comparison with Teradyne’s business plan, historical gross margin results and the gross margin results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

Page 3


About Teradyne

Teradyne (NASDAQ:TER) brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its Industrial Automation offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. In 2019, Teradyne had revenue of $2.3 billion and today employs 5,500 people worldwide. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements regarding Teradyne’s future business prospects, the impact of the COVID-19 outbreak, results of operations, market conditions, earnings per share, the payment of a quarterly dividend, the repurchase of Teradyne common stock pursuant to a share repurchase program, and the impact of the U.S. export and tariff laws. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance, events, earnings per share, use of cash, payment of dividends, repurchases of common stock, payment of the senior convertible notes, the impact of the COVID-19 outbreak, or the impact of the U.S. export and tariff laws. There can be no assurance that management’s estimates of Teradyne’s future results or other forward-looking statements will be achieved. Additionally, the current dividend program may be modified, suspended or discontinued at any time.

On May 16, 2019, Huawei and 68 of its affiliates, including HiSilicon, were added to the U.S. Department of Commerce Entity List under U.S. Export Administration Regulations (the “EAR”). This action by the U.S. Department of Commerce imposed new export licensing requirements on exports, re-exports, and in-country transfers of all U.S.—regulated products, software and technology to the designated Huawei entities. While most of Teradyne’s products are not subject to the EAR and therefore not affected by the Entity List restrictions, some of its products are currently manufactured in the U.S. and thus subject to the Entity List restrictions. Compliance with the current Entity List restrictions has not significantly impacted Teradyne’s sales. There have been recent news reports that the U.S. Department of Commerce plans to modify the U.S. EAR to expand the scope of the regulations to include additional products that would become subject to the Entity List restrictions relating to Huawei and the designated Huawei entities including HiSilicon. These modified regulations, if implemented as currently reported, may impact Teradyne’s sales to third party contract manufacturers used by Huawei and HiSilicon to manufacture and test semiconductor and other electronic devices. Because the business environment for Huawei is both fluid and uncertain, there are also risks that Huawei, HiSilicon and their third party contract manufacturers may have less demand for Teradyne’s products and/or may purchase products from Teradyne’s competitors who are not impacted by the U.S. regulations. Until these or any new regulations become public and effective, Teradyne will not know the extent of the impact on its business with Huawei, HiSilicon and their third party contract manufacturers. However, it is possible that these modified regulations and any other additional regulations that may be implemented by the U.S. Department of Commerce or other government agency would have a material impact on Teradyne’s business and financial results.

Page 4


The global outbreak of the recent novel strain of the coronavirus (COVID-19) has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place orders, and shutdowns. These measures have impacted and may further impact Teradyne’s workforce and operations, the operations of its customers, and those of its contract manufacturers and suppliers. Teradyne management believes COVID-19 has adversely impacted its results of operations, including increased costs, but cannot accurately estimate the amount of the impact for Teradyne’s first quarter 2020 financial results and to its future financial results. There is considerable uncertainty regarding the impact on Teradyne’s business from the measures in place and potential future measures, and restrictions on Teradyne’s access to its manufacturing facilities or on its support operations or workforce, or similar limitations for its contractor manufacturers and suppliers, and restrictions or disruptions of transportation, such as reduced availability of transportation and increased border controls or closures, could limit Teradyne’s capacity to meet customer demand and have a material adverse effect on its financial condition and results of operations. The COVID-19 outbreak has significantly increased economic and demand uncertainty in Teradyne’s markets. This uncertainty could result in a significant decrease in demand for Teradyne’s products for an uncertain period of time. The spread of COVID-19 has caused Teradyne to modify its business practices (including employee travel, employees working remotely, and cancellation of physical participation in meetings, events and conferences), and the company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, contract manufacturers and suppliers. There is uncertainty that such measures will be sufficient to mitigate the risks posed by the virus, and Teradyne’s ability to perform critical functions could be harmed. Due to the uncertainty regarding the length, severity and potential business impact of the COVID-19 pandemic, Teradyne has suspended its stock repurchase program. In January 2020, Teradyne announced its intention to repurchase $250 million in shares in 2020. At this time, Teradyne does not know whether or when it will continue its 2020 repurchase plan or authorize future stock repurchase programs. The degree to which COVID-19 impacts Teradyne’s results will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and continued spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.

Important factors that could cause actual results, earnings per share, use of cash, dividend payments, repurchases of common stock, or payment of the senior convertible notes to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; development, delivery and acceptance of new products; the ability to grow the Industrial Automation business; increased research and development spending; deterioration of Teradyne’s financial condition; the impact of the COVID-19 outbreak and related government responses on the market and demand for Teradyne’s products, on its contract manufacturers and supply chain, and on its workforce; the

Page 5


consummation and success of any mergers or acquisitions; unexpected cash needs; insufficient cash flow to make required payments and pay the principal amount on the senior convertible notes; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in the company’s best interests; additional U.S. tax regulations or IRS guidance; the impact of any tariffs or export controls imposed in the U.S. or China; compliance with trade protection measures or export restrictions; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei and HiSilicon; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management’s views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne’s views as of any date subsequent to the date of this release.




(In thousands, except per share amounts)



     Quarter Ended  
     March 29,
    December 31,
    March 31,

Net revenues

   $ 704,355     $ 654,650     $ 494,099  

Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)

     298,805       271,412       206,464  










Gross profit

     405,550       383,238       287,635  

Operating expenses:


Selling and administrative

     111,388       117,092       102,013  

Engineering and development

     85,159       86,794       76,791  

Acquired intangible assets amortization

     9,891       9,784       10,634  

Restructuring and other (2)

     (7,606     (2,088     5,112  










Operating expenses

     198,832       211,582       194,550  

Income from operations

     206,718       171,656       93,085  

Interest and other expense (3)

     9,649       22,770       (894










Income before income taxes

     197,069       148,886       93,979  

Income tax provision (benefit)

     20,878       23,811       (15,159










Net income

   $ 176,191     $ 125,075     $ 109,138  











Net income per common share:




   $ 1.06     $ 0.75     $ 0.63  











   $ 0.97     $ 0.69     $ 0.62  











Weighted average common shares — basic

     166,589       167,286       173,532  











Weighted average common shares — diluted (4)

     180,736       181,780       176,972  











Cash dividend declared per common share

   $ 0.10     $ 0.09     $ 0.09  









(1)    Cost of revenues includes:    Quarter Ended  
     March 29,
    December 31,
    March 31,

Provision for excess and obsolete inventory

   $ 4,057     $ 6,396     $ 2,397  

Sale of previously written down inventory

     (1,077     (1,222     (778

Inventory step-up

     118       64       —    









   $ 3,098     $ 5,238     $ 1,619  









(2)    Restructuring and other consists of:    Quarter Ended  
     March 29,
    December 31,
    March 31,

Contingent consideration fair value adjustment

   $ (10,020   $ (2,796   $ 2,970  

Acquisition related expenses and compensation

     1,358       248       1,343  

Employee severance

     728       460       799  


     328       —         —    









   $ (7,606   $ (2,088   $ 5,112  









(3)    Interest and other includes:    Quarter Ended  
     March 29,
    December 31,
    March 31,

RealWear investment impairment

   $ —       $ 15,000     $ —    

Non-cash convertible debt interest

     3,540       3,496       3,368  

Pension actuarial loss

     —         7,727       —    









   $ 3,540     $ 26,223     $ 3,368  












Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, 7.3 million, 7.3 million and 2.2 million shares, respectively, have been included in diluted shares. For the three months ended March 29, 2020, and December 31, 2019, diluted shares also included 5.5 million and 5.4 million shares, respectively, from the convertible note hedge transaction.




     March 29,
     December 31,



Cash and cash equivalents

   $ 593,494      $ 773,924  

Marketable securities

     211,001        137,303  

Accounts receivable, net

     487,365        362,368  

Inventories, net

     182,978        196,691  

Prepayments and other current assets

     227,740        188,598  








Total current assets

     1,702,578        1,658,884  

Property, plant and equipment, net

     332,241        320,216  

Operating lease right-of-use assets, net

     58,808        57,539  

Marketable securities

     100,513        104,490  

Deferred tax assets

     74,493        75,185  

Retirement plans assets

     18,229        18,457  

Other assets

     9,272        10,332  

Acquired intangible assets, net

     114,321        125,480  


     409,933        416,431  







Total assets

   $ 2,820,388      $ 2,787,014  









Accounts payable

   $ 129,633      $ 126,617  

Accrued employees’ compensation and withholdings

     119,226        163,883  

Deferred revenue and customer advances

     98,815        104,876  

Other accrued liabilities

     87,274        70,871  

Operating lease liabilities

     19,591        19,476  

Contingent consideration

     662        9,106  

Income taxes payable

     58,760        44,200  








Total current liabilities

     513,961        539,029  

Retirement plans liabilities

     125,970        134,471  

Long-term deferred revenue and customer advances

     50,791        45,974  

Deferred tax liabilities

     11,628        14,070  

Long-term other accrued liabilities

     19,941        19,535  

Long-term contingent consideration

     19,810        30,599  

Long-term operating lease liabilities

     46,328        45,849  

Long-term income taxes payable

     82,820        82,642  


     398,466        394,687  







Total liabilities

     1,269,715        1,306,856  








Shareholders’ equity

     1,550,673        1,480,158  







Total liabilities and shareholders’ equity

   $ 2,820,388      $ 2,787,014  










     Quarter Ended  
     March 29,
    March 31,

Cash flows from operating activities:


Net income

   $ 176,191     $ 109,138  

Adjustments to reconcile net income to net cash provided by operating activities:



     18,489       16,651  


     13,391       12,942  

Stock-based compensation

     10,460       9,474  

Provision for excess and obsolete inventory

     4,057       2,397  

Losses (gains) on investments

     4,657       (2,828

Deferred taxes

     (1,825     1,206  

Contingent consideration fair value adjustment

     (10,020     2,970  


     503       219  

Changes in operating assets and liabilities, net of businesses acquired:


Accounts receivable

     (126,779     (41,706


     15,818       (2,917

Prepayments and other assets

     (39,620     (18,648

Accounts payable and other liabilities

     (35,323     (53,323

Deferred revenue and customer advances

     (913     6,455  

Retirement plans contributions

     (1,262     (1,210

Income taxes

     15,278       (22,804







Net cash provided by operating activities

     43,102       18,016  







Cash flows from investing activities:


Purchases of property, plant and equipment

     (36,700     (25,711

Purchases of marketable securities

     (187,119     (375,184

Proceeds from maturities of marketable securities

     98,457       141,201  

Proceeds from sales of marketable securities

     15,005       5,440  

Acquisition of businesses, net of cash acquired

     149       (6,970

Proceeds from life insurance

     —         273  







Net cash used for investing activities

     (110,208     (260,951







Cash flows from financing activities:


Issuance of common stock under stock purchase and stock option plans

     12,752       14,268  

Repurchase of common stock

     (79,039     (156,468

Dividend payments

     (16,686     (15,627

Payments related to net settlement of employee stock compensation awards

     (22,070     (14,318

Payments of contingent consideration

     (8,852     (27,615







Net cash used for financing activities

     (113,895     (199,760







Effects of exchange rate changes on cash and cash equivalents

     571       (329







Decrease in cash and cash equivalents

     (180,430     (443,024

Cash and cash equivalents at beginning of period

     773,924       926,752  







Cash and cash equivalents at end of period

   $ 593,494     $ 483,728  







GAAP to Non-GAAP Earnings Reconciliation

(In millions, except per share amounts)


    Quarter Ended  
    March 29,
    % of Net
                December 31,
    % of Net
                March 31,
    % of Net

Net revenues

  $ 704.4           $ 654.7           $ 494.1        

Gross profit GAAP and non-GAAP

  $ 405.6       57.6       $ 383.2       58.5       $ 287.6       58.2    

Inventory step-up

    0.1       0.0         0.1       0.0         —         —        



















Gross profit non-GAAP

  $ 405.7       57.6       $ 383.3       58.5       $ 287.6       58.2    

Income from operations — GAAP

  $ 206.7       29.3       $ 171.7       26.2       $ 93.1       18.8    

Acquired intangible assets amortization

    9.9       1.4         9.8       1.5         10.6       2.1    

Restructuring and other (1)

    (7.6     -1.1         (2.1     -0.3         5.1       1.0    

Inventory step-up

    0.1       0.0         0.1       0.0         —         —        



















Income from operations — non-GAAP

  $ 209.1       29.7       $ 179.5       27.4       $ 108.8       22.0    


















                Net Income
per Common
                Net Income
per Common
                Net Income
per Common
    March 29,
    % of Net
    Basic     Diluted     December 31,
    % of Net
    Basic     Diluted     March 31,
    % of Net
    Basic     Diluted  

Net income — GAAP

  $ 176.2       25.0   $ 1.06     $ 0.97     $ 125.1       19.1   $ 0.75     $ 0.69     $ 109.1       22.1   $ 0.63     $ 0.62  

Acquired intangible assets amortization

    9.9       1.4     0.06       0.05       9.8       1.5     0.06       0.05       10.6       2.1     0.06       0.06  

Interest and other (2)

    3.5       0.5     0.02       0.02       18.5       2.8     0.11       0.10       3.4       0.7     0.02       0.02  

Restructuring and other (1)

    (7.6     -1.1     (0.05     (0.04     (2.1     -0.3     (0.01     (0.01     5.1       1.0     0.03       0.03  

Pension mark-to-market adjustment (2)

    —         —         —         —         7.7       1.2     0.05       0.04       —         —         —         —    

Inventory step-up

    0.1       0.0     0.00       0.00       0.1       0.0     0.00       0.00       —         —         —         —    

Exclude discrete tax adjustments (3)

    (7.7     -1.1     (0.05     (0.04     1.4       0.2     0.01       0.01       (30.1     -6.1     (0.17     (0.17

Non-GAAP tax adjustments

    (1.9     -0.3     (0.01     (0.01     (7.8     -1.2     (0.05     (0.04     (3.5     -0.7     (0.02     (0.02

Convertible share adjustment (4)

    —         —         —         0.04       —         —         —         0.03       —         —         —         0.01  





































Net income — non-GAAP (4)

  $ 172.5       24.5   $ 1.04     $ 1.00     $ 152.7       23.3   $ 0.91     $ 0.88     $ 94.6       19.1   $ 0.55     $ 0.54  





































GAAP and non-GAAP weighted average common shares — basic

    166.6             167.3             173.5        

GAAP weighted average common shares — diluted

    180.7             181.8             177.0        

Exclude dilutive shares related to convertible note transaction

    (7.3           (7.3           (2.2      










Non-GAAP weighted average common shares — diluted

    173.4             174.5             174.8        










(1)    Restructuring and other consists of:


    Quarter Ended                    
    March 29,
                      December 31,
                      March 31,

Contingent consideration fair value adjustment

  $ (10.0         $ (2.8         $ 3.0        

Acquisition related expenses and compensation

    1.4             0.2             1.3        

Employee severance

    0.7             0.5             0.8        


    0.3             —               —          









  $ (7.6         $ (2.1         $ 5.1        











For the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, adjustment to exclude non-cash convertible debt interest expense. For the quarter ended December 31, 2019 adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting and adjustment to exclude RealWear $15.0 million investment impairment.



For the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, adjustment to exclude discrete income tax items. For the quarter ended March 31, 2019, income tax (benefit) provision includes a $26 million tax benefit from the release of uncertain tax position reserves due to the IRS completion of its audit of Teradyne’s 2015 Federal tax return.



For the quarters ended March 29, 2020 and December 31, 2019, the non-GAAP diluted EPS calculation adds back $1.3 million of convertible debt interest expense to non-GAAP net income and non-GAAP weighted average diluted common shares include 5.5 million and 5.4 million shares, respectively, related to the convertible debt hedge transaction.


GAAP to Non-GAAP Reconciliation of Second Quarter 2020 guidance:


GAAP and non-GAAP second quarter revenue guidance:

   $ 690 million       to      $ 800 million  

GAAP net income per diluted share

   $ 0.76        $ 1.05  

Exclude acquired intangible assets amortization

     0.06          0.06  

Exclude non-cash convertible debt interest

     0.02          0.02  

Tax effect of non-GAAP adjustments

     (0.02        (0.02

Convertible share adjustment

     0.04          0.05  







Non-GAAP net income per diluted share

   $ 0.86        $ 1.16  

For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.


Contact: Teradyne, Inc.


Andy Blanchard 978-370-2425


Vice President of Corporate Relations